Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A high-tech diary aims to cut nighttime bathroom visits without medication

NCT ID NCT07734207

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This pilot study tests whether a home uroflowmetry device paired with a smartphone app and personalized lifestyle advice can reduce nocturia—waking up to urinate two or more times a night—in adults aged 55 and older. Participants track their voiding patterns and receive real-time feedback, along with guidance on fluid intake and sleep hygiene. The goal is to see if this digital, non-drug approach can improve sleep quality and reduce the need for medication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a home uroflowmetry device and a voiding diary combined with lifestyle guidance
What this could lead to
If it works, this could offer a drug-free way to manage nocturia and improve sleep and quality of life for older adults.
What could go wrong
This is a small pilot study, so results may not apply widely. The approach relies on consistent use of the device and diary, which may be challenging for some participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Baseline nocturia frequency ≥ 2 times/night (confirmed by subjective report or simplified questionnaire). 2. Ability to operate LINE on a smartphone or have a caregiver assist with completing the electronic urinary diary. Exclusion Criteria: 1. Acute urinary tract infection 2. Uncontrolled heart failure 3. Serum sodium \< 130 mEq/L 4. Underwent urological surgery within the past three months 5. Major psychiatric or neurological disorder in an active phase, (GDS-15\>5) 6. Participation in other clinical trials related to nocturia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nocturia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Yunlin HI-HOPE Community Hub

    RECRUITING

    Douliu, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.